CA 19-9
A tumour marker. Although CA 19.9 is frequently elevated in patients with Ca pancreas and is used for monitoring therapy, it is not useful in the diagnosis of Ca pancreas.
| Tube | 01 (SE) - Serum Gel |
|---|---|
| ID | Tests&Tubes0027 |
| Additional Information | 5% of the population cannot synthesise CA 19-9 (individuals with Lewis neg blood group antigens). Elevations may be seen in cirrhosis and benign biliary tract disease. PLEASE NOTE: TEST CAN ONLY BE ADDED TO A SAMPLE WITHIN 8 HOURS OF COLLECTION |
| Turn Around | A&E: N/A Day Case: N/A In-Patient: 48 Hours Out-Patient: 48 Hours GP: N/A |
| Send to | Blood Sciences Cross Site |
| Contact | For further details please contact Leeds Pathology customer services: leedsth-tr.pathologycustomerservice@nhs.net. |
| Collection Con | Minimum volume - 300µl serum / plasma Instructions for Lab Staff: Standard lab processing- No special requirements |
| Sample REQ | Blood |
| Ref. Range Notes | Blood Sciences reference ranges are available through the useful information and links page: https://www.leedsth.nhs.uk/a-z-of-services/pathology/blood-sciences/useful-information-and-links/ |
| Units | ku/L |
| Telepath | C1991L |
| ICE Codes | LC199 |
